FDA Places CARsgen Therapeutics’ CAR-T Cell Therapies on Clinical Hold, Impacts Global Expansion Plans

December 18, 2023

NovAliX Joins Hands With Max Planck Institute on Cancer Pact

March 7, 2024

FDA Advisory Committee Recommends Agency Approve Two RSV Shots

March 18, 2023

Must Read

AI in Medical Affairs: How Pharma Is Becoming a Real-Time Scientific Intelligence System

June 2, 2026

Are Pharmaceutical Companies Moving Too Fast With AI Adoption?

June 2, 2026

For CAR-T biotech InnocsAI, struggling Liminatus pays $320 million in equity

June 2, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Early research shows that Lilly’s Verve strategy is successful in lowering cholesterol

Kailera Details Nasdaq IPO Plans to Raise Up to $528.5 Million for Obesity Drug Development

Avalyn Files for IPO to Fund Late-Stage Development of Inhaled Lung Disease Therapies

Merck Pays $20 Million Upfront to Access Quotient’s Somatic Genomics Platform for IBD Research

After a phase 2 failure, Biogen ends Parkinson’s prospects with Denali

Kelun Reports Positive Phase 3 Results for sac-TMT With Keytruda in First-Line NSCLC

Eli Lilly’s VERVE-102 Shows Up to 62% LDL Cholesterol Reduction in Early Trial

Agios Halts Tebapivat Development in LR-MDS After Phase 2b Trial Misses Primary Endpoint

For CAR-T biotech InnocsAI, struggling Liminatus pays $320 million in equity

Lilly Pens $3.8B Deal to Purchase 3 Vaccine Developers Amidst M&A Spree

Pfizer and Innovent sign a $10 billion, 12-drug pact in a large wager on Chinese cancer medicine research

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

AI in Medical Affairs: How Pharma Is Becoming a Real-Time Scientific Intelligence System

Are Pharmaceutical Companies Moving Too Fast With AI Adoption?

From Pilots to Scale: Why Most Healthcare AI Projects Stall

Why Life Sciences Leaders Are Reassessing Their Cloud Strategies

Tag: InnocsAI

For CAR-T biotech InnocsAI, struggling Liminatus pays $320 million in equity

Editor Picks

FDA Places CARsgen Therapeutics’ CAR-T Cell Therapies on Clinical Hold, Impacts Global Expansion Plans

NovAliX Joins Hands With Max Planck Institute on Cancer Pact

FDA Advisory Committee Recommends Agency Approve Two RSV Shots

Must Read

AI in Medical Affairs: How Pharma Is Becoming a Real-Time Scientific Intelligence System

Are Pharmaceutical Companies Moving Too Fast With AI Adoption?

For CAR-T biotech InnocsAI, struggling Liminatus pays $320 million in equity

Hot Topics

About Us

Follow Us